HK1177694A1 - Calcipotriol monohydrate nanocrystals - Google Patents

Calcipotriol monohydrate nanocrystals

Info

Publication number
HK1177694A1
HK1177694A1 HK13104896.2A HK13104896A HK1177694A1 HK 1177694 A1 HK1177694 A1 HK 1177694A1 HK 13104896 A HK13104896 A HK 13104896A HK 1177694 A1 HK1177694 A1 HK 1177694A1
Authority
HK
Hong Kong
Prior art keywords
calcipotriol monohydrate
monohydrate nanocrystals
nanocrystals
calcipotriol
monohydrate
Prior art date
Application number
HK13104896.2A
Other languages
English (en)
Chinese (zh)
Inventor
Karsten Petersson
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of HK1177694A1 publication Critical patent/HK1177694A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/21Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13104896.2A 2009-12-22 2013-04-23 Calcipotriol monohydrate nanocrystals HK1177694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK2009000267 2009-12-22
US29309110P 2010-01-07 2010-01-07
PCT/DK2010/000183 WO2011076208A2 (fr) 2009-12-22 2010-12-22 Nanocristaux de monohydrate de calcipotriol

Publications (1)

Publication Number Publication Date
HK1177694A1 true HK1177694A1 (en) 2013-08-30

Family

ID=43618145

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13104896.2A HK1177694A1 (en) 2009-12-22 2013-04-23 Calcipotriol monohydrate nanocrystals

Country Status (16)

Country Link
US (2) US20130039952A1 (fr)
EP (1) EP2515874B1 (fr)
JP (1) JP5816194B2 (fr)
CN (1) CN102770125B (fr)
AU (1) AU2010335655B2 (fr)
BR (1) BR112012015449B1 (fr)
CA (1) CA2785253A1 (fr)
ES (1) ES2523119T3 (fr)
HK (1) HK1177694A1 (fr)
IL (1) IL220516A (fr)
MX (1) MX2012007234A (fr)
NZ (1) NZ601000A (fr)
PL (1) PL2515874T3 (fr)
RU (1) RU2555339C2 (fr)
WO (1) WO2011076208A2 (fr)
ZA (1) ZA201204618B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105534996B (zh) * 2016-02-24 2018-05-01 长沙佰顺生物科技有限公司 一种治疗银屑病的药物组合物
US11522178B2 (en) 2016-07-05 2022-12-06 Kratos LLC Passivated pre-lithiated micron and sub-micron group IVA particles and methods of preparation thereof
WO2018183909A1 (fr) * 2017-03-31 2018-10-04 Kratos LLC Matériau d'électrode négative préchargé pour batterie secondaire
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CN109157661B (zh) * 2018-09-10 2021-09-24 南京工业大学 一种配体辅助下用氧化物silica包覆疏水性分子晶体的方法
RU2749360C1 (ru) * 2020-10-09 2021-06-09 Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) Способ лечения ладонно-подошвенного пустулеза

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
US4758432A (en) * 1984-10-15 1988-07-19 Richardson-Vicks Inc. Topical treatment of skin inflammatory disorders
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
DE19932157A1 (de) 1999-07-13 2001-01-18 Pharmasol Gmbh Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
AU9163701A (en) * 2000-10-27 2002-05-06 Leo Pharma As Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
JP2004518642A (ja) * 2000-12-06 2004-06-24 ファルマシア・コーポレーション ラボラトリースケールの微粉砕化プロセス
FR2834212B1 (fr) * 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
CA2509101A1 (fr) 2002-12-13 2004-07-01 Jagotec Ag Preparation topique de spironolactone nanoparticulaire
ATE469878T1 (de) 2003-07-24 2010-06-15 Leo Pharma As Aminobenzophenonverbindungen
CA2565236A1 (fr) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particules pour la liberation d'agents actifs
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
RU2394818C2 (ru) 2004-12-13 2010-07-20 Лео Фарма А/С Триазолзамещенные аминобензофеноновые соединения
AU2006253913B2 (en) * 2005-06-01 2010-09-16 Mayne Pharma Llc Vitamin formulation
EP1948130B1 (fr) * 2005-10-24 2013-09-11 Precision Dermatology, Inc. Composition de mousse pharmaceutique topique
IN2014MN00380A (fr) * 2006-06-30 2015-06-19 Iceutica Pty Ltd
WO2008058755A1 (fr) 2006-11-17 2008-05-22 Abbott Gmbh & Co. Kg Nanocristaux pour une utilisation dans des formulations cosmétiques topiques et leur procédé de fabrication
PT2125736E (pt) 2006-12-22 2011-07-01 Leo Pharma As Acetofenonas substituídas úteis como inibidores de pde4
NZ578804A (en) 2007-02-28 2012-04-27 Leo Pharma As Spirocyclic phosphodiesterase inhibitors
JP2010524864A (ja) 2007-04-19 2010-07-22 レオ ファーマ アクティーゼルスカブ Srcファミリーキナーゼ阻害剤
EP2146780A1 (fr) 2007-05-11 2010-01-27 Sonneborn Inc. Petrolatums presentant de proprietes de type silicone
US8952162B2 (en) 2008-12-19 2015-02-10 Leo Pharma A/S Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases

Also Published As

Publication number Publication date
RU2012130412A (ru) 2014-01-27
IL220516A (en) 2015-06-30
PL2515874T3 (pl) 2015-01-30
WO2011076208A2 (fr) 2011-06-30
JP5816194B2 (ja) 2015-11-18
JP2013515019A (ja) 2013-05-02
US20130039952A1 (en) 2013-02-14
CA2785253A1 (fr) 2011-06-30
CN102770125A (zh) 2012-11-07
MX2012007234A (es) 2012-07-30
EP2515874B1 (fr) 2014-08-20
ZA201204618B (en) 2013-09-25
ES2523119T3 (es) 2014-11-21
BR112012015449A2 (pt) 2016-03-15
WO2011076208A3 (fr) 2012-03-01
CN102770125B (zh) 2015-02-11
AU2010335655A1 (en) 2012-07-19
BR112012015449B1 (pt) 2021-09-28
RU2555339C2 (ru) 2015-07-10
US20140322331A1 (en) 2014-10-30
AU2010335655B2 (en) 2015-03-05
EP2515874A2 (fr) 2012-10-31
NZ601000A (en) 2014-07-25

Similar Documents

Publication Publication Date Title
EP2452898A4 (fr) Chariot convoyeur au plafond
ZA201203442B (en) Transport unit
EP2439587A4 (fr) Projecteur
IL220526A0 (en) Kokumi-imparting agent
EP2478768A4 (fr) Agent antiphytoviral
IL220527A0 (en) Kokumi-imparting agent
PL2454139T3 (pl) Rama podwozia do pojazdów szynowych
PL2228278T3 (pl) Wagon
EP2452679A4 (fr) Agent cytoprotecteur
EP2509287A4 (fr) Mécanisme de coulissement-inclinaison
HK1177694A1 (en) Calcipotriol monohydrate nanocrystals
SG10201406420XA (en) Antiproliferative agent
EP2433502A4 (fr) Agent de suppression d'amertume
AU330337S (en) Truck
HK1140909A2 (en) Show off
PL2339068T3 (pl) Tor kolejowy
GB0921275D0 (en) Curtain-sided trailer
GB0919653D0 (en) Sutters for cars
GB0900725D0 (en) Cargo offloader
GB2473269B (en) Emergency device-access
GB0903731D0 (en) Trailer
GB0910034D0 (en) Displat trailer
PL387444A1 (pl) Transporter buforowy
GB0919065D0 (en) Nanotechnology commodities
TWM370405U (en) Driving structure for respirator